Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device Post author:Sam Post published:August 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sysmex AmericaTo Distribute Erythrocyte Sedimentation Rate Products From Alifax S.p.A. February 19, 2017 Safety Issues Force the FDA to Turn Down Amgen, UCB SA's Osteoporosis Drug July 16, 2017 Axovant's Nightmare Week Continues After CEO Admits Numbers Were Even Worse Than Reported Yesterday January 8, 2018
Sysmex AmericaTo Distribute Erythrocyte Sedimentation Rate Products From Alifax S.p.A. February 19, 2017
Axovant's Nightmare Week Continues After CEO Admits Numbers Were Even Worse Than Reported Yesterday January 8, 2018